News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
870,145 Results
Type
Article (87980)
Company Profile (825)
Press Release (781321)
Multimedia
Podcasts (196)
Webinars (28)
Section
Business (233268)
Career Advice (4147)
Deals (39883)
Drug Delivery (151)
Drug Development (91420)
Employer Resources (205)
FDA (18392)
Job Trends (17428)
News (397930)
Policy (39970)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3011)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (147)
Alliances (56981)
ALS (181)
Alzheimer's disease (1789)
Antibody-drug conjugate (ADC) (346)
Approvals (18574)
Artificial intelligence (626)
Autoimmune disease (161)
Automation (36)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (201)
Biotechnology (490)
Bladder cancer (162)
Brain cancer (65)
Breast cancer (662)
Cancer (5030)
Cardiovascular disease (443)
Career advice (3570)
Career pathing (41)
CAR-T (303)
CDC (59)
Celiac Disease (1)
Cell therapy (825)
Cervical cancer (37)
Clinical research (77015)
Collaboration (1811)
Company closure (5)
Compensation (1152)
Complete response letters (70)
COVID-19 (2992)
CRISPR (99)
C-suite (860)
Cystic fibrosis (154)
Data (6258)
Decentralized trials (2)
Denatured (72)
Depression (150)
Diabetes (532)
Diagnostics (7226)
Digital health (47)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (302)
Drug pricing (223)
Drug shortages (36)
Duchenne muscular dystrophy (239)
Earnings (100139)
Editorial (64)
Employer branding (25)
Employer resources (173)
Events (135067)
Executive appointments (1033)
FDA (21567)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1554)
Gene editing (215)
Generative AI (64)
Gene therapy (670)
GLP-1 (1125)
Government (5441)
Grass and pollen (8)
Guidances (385)
Healthcare (20945)
HIV (60)
Huntington's disease (49)
IgA nephropathy (86)
Immunology and inflammation (290)
Immuno-oncology (59)
Indications (96)
Infectious disease (3279)
Inflammatory bowel disease (206)
Inflation Reduction Act (17)
Influenza (120)
Intellectual property (247)
Interviews (816)
IPO (17954)
IRA (60)
Job creations (5200)
Job search strategy (2866)
JPM (68)
Kidney cancer (17)
Labor market (93)
Layoffs (660)
Leadership (40)
Legal (10160)
Liver cancer (98)
Longevity (16)
Lung cancer (679)
Lymphoma (378)
Machine learning (45)
Management (66)
Manufacturing (850)
MASH (172)
Medical device (15027)
Medtech (15079)
Mergers & acquisitions (22984)
Metabolic disorders (1394)
Multiple sclerosis (161)
NASH (23)
Neurodegenerative disease (354)
Neuropsychiatric disorders (97)
Neuroscience (3105)
Neurotech (1)
NextGen: Class of 2026 (7708)
Non-profit (5112)
Now hiring (66)
Obesity (674)
Opinion (335)
Ovarian cancer (166)
Pain (209)
Pancreatic cancer (231)
Parkinson's disease (300)
Partnered (39)
Patents (508)
Patient recruitment (478)
Peanut (60)
People (66908)
Pharmaceutical (145)
Pharmacy benefit managers (32)
Phase I (23798)
Phase II (33418)
Phase III (25186)
Pipeline (5015)
Policy (336)
Postmarket research (3554)
Preclinical (10692)
Press Release (72)
Prostate cancer (245)
Psychedelics (54)
Radiopharmaceuticals (301)
Rare diseases (897)
Real estate (7439)
Recruiting (80)
Regulatory (29010)
Reports (67)
Research institute (2725)
Resumes & cover letters (651)
Rett syndrome (27)
RNA editing (20)
RSV (83)
Schizophrenia (158)
Series A (257)
Series B (197)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (176)
Sponsored (48)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (113)
Tariffs (100)
The Weekly (122)
Vaccines (1147)
Venture capital (96)
Weight loss (462)
Women's health (87)
Worklife (21)
Date
Today (13)
Last 7 days (502)
Last 30 days (2419)
Last 365 days (32747)
2026 (2456)
2025 (33230)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (89)
Alaska (7)
Arizona (343)
Arkansas (14)
Asia (51556)
Australia (9053)
California (11520)
Canada (3308)
China (1164)
Colorado (488)
Connecticut (499)
Delaware (345)
Europe (118440)
Florida (1686)
Georgia (369)
Hawaii (4)
Idaho (68)
Illinois (963)
India (67)
Indiana (542)
Iowa (24)
Japan (427)
Kansas (133)
Kentucky (43)
Louisiana (29)
Maine (83)
Maryland (1456)
Massachusetts (8483)
Michigan (358)
Minnesota (664)
Mississippi (6)
Missouri (139)
Montana (35)
Nebraska (29)
Nevada (126)
New Hampshire (86)
New Jersey (3102)
New Mexico (33)
New York (3043)
North Carolina (1609)
North Dakota (10)
Northern California (5508)
Ohio (354)
Oklahoma (22)
Oregon (54)
Pennsylvania (2307)
Puerto Rico (22)
Rhode Island (50)
South America (1661)
South Carolina (65)
South Dakota (1)
Southern California (4445)
Tennessee (176)
Texas (1817)
United States (41578)
Utah (346)
Vermont (1)
Virginia (290)
Washington D.C. (88)
Washington State (970)
West Virginia (4)
Wisconsin (126)
Wyoming (2)
There are 870,145 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ProMIS Neurosciences Announces Up to $175 Million Private Placement Financing
February 1, 2026
·
7 min read
Press Releases
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - January 30, 2026
February 1, 2026
·
3 min read
Press Releases
Polaryx Therapeutics Announces Approval to List Common Stock on Nasdaq
February 1, 2026
·
4 min read
Press Releases
IO Biotech Provides Corporate Update - January 30, 2026
February 1, 2026
·
2 min read
Press Releases
New Data Demonstrate CD47 Expression Level Helps Predict Response to ALX Oncology’s Evorpacept in Combination with Ziihera (zanidatamab-hrii) in Advanced HER2-Positive Breast Cancer
February 1, 2026
·
4 min read
Press Releases
Dr. David Berman to Join Moderna as Chief Development Officer
February 1, 2026
·
4 min read
Press Releases
Press Release: Sanofi’s Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease
February 1, 2026
·
8 min read
Press Releases
Immunocore announces R&D leadership evolution
February 1, 2026
·
6 min read
Press Releases
Tonix Pharmaceuticals Presented Phase 3 RESILIENT Data on TONMYA™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2026 Non-Opioid Pain Therapeutics Summit
February 1, 2026
·
12 min read
Press Releases
Johnson & Johnson receives CHMP positive opinion for AKEEGA® (niraparib and abiraterone acetate dual action tablet) for the treatment of patients with metastatic hormone-sensitive prostate cancer (mHSPC) with BRCA1/2 mutations
February 1, 2026
·
10 min read
1 of 87,015
Next
